OB/GYN Clinical Alert – October 1, 2007
October 1, 2007
View Issues
-
MRI for Diagnosis of Breast Ductal Carcinoma In Situ
Kuhl and colleagues from the University of Bonn, Germany, compared the sensitivity of mammography and MRI for the diagnosis of breast ductal carcinoma in situ (DCIS). -
Oral Contraceptives and Risk of Myocardial Infarction
Margolis and colleagues analyzed data from a large prospective study of a cohort of 48,321 Swedish women who are part of the Women's Lifestyle and Health Cohort Study. -
Increased Risk of Cognitive Impairment or Dementia in Women Who Underwent Oophorectomy before Menopause
The present study indirectly tested the hypothesis that estrogen exposure is neuroprotective by studying the risk of dementia in women who underwent oophorectomy premenopausally. All women residing in Olmstead, MN, from 1950 to 1987 who underwent unilateral or bilateral oophorectomy were followed through death or end of study (staggered from 2001 to 2006). -
Detailed Pathological Assessment of Fallopian Tube Paramount in Women Undergoing Prophylactic BSO for BRCA Mutation
The performance of risk-reducing surgery in women with BRCA mutation has a profound effect on the potential for subsequent cancer development. While gross tumor is occasionally identified in these specimens, it is more common that pathological processing identifies occult cancer. -
Advancing the 'Comfort Zone' with Laparoscopic Gynecologic Oncology
Advances in laparoscopic instrumentation and surgical skill have enabled the adoption of oncologic procedures traditionally approached via ceiliotomy to the minimally invasive modality. However, little comparative data are available on some of the most complex of these operations. -
Special Feature: Is There Value in CA125 Distinguishing Benign from Malignant Ovarian Tumors?
CA-125 measurements alone or as part of a multimodal strategy are routinely used clinically to aid in developing a treatment plan for women with adnexal masses. -
Pharmacology Watch: Stopping Statins in At-Risk Patients — Just Too Risky
Mupirocin Less Effective Against MRSA; New Guideline for Asthma Diagnosis/Management; FDA Actions -
Clinical Briefs in Primary Care supplement